Large Cap Biopharma: January ’17 Update

Large Cap Biopharmaceuticals: Jan. 2016 Compared to Jan.2017

• Stock prices are compared for the one year bear market 1/7/16-1/31/17.
• Financial metrics will be updated after all earnings are reported.
• Dividends have gone up with stock prices down: ABBV, BMY, AMGN, GILD.
• Only one stock is up YoY: Celgene (CELG) up 2%.
• XBI is up 5% YoY; IBB is down 8.6%.